A new Northwestern Medicine study challenges a common belief in what triggers Parkinson’s disease.
ITM follows €255M investment round by opening new facility
After a recent funding announcement, Isotope Technologies Munich SE (ITM), a radiopharmaceutical biotech company, has opened its new production facility for therapeutic radionuclides in Neufahrn